
- Telehealth visits
- Insurance plan information

Jonathan Lu, MD
Ophthalmology (Ophthalmic Plastic and Reconstructive Surgery)- Telehealth visits
- Insurance plan information



Jonathan Lu, MD
Ophthalmology (Ophthalmic Plastic and Reconstructive Surgery)- Telehealth visits
- Insurance plan information
On this page
Education & training
Board certification
- Ophthalmology, American Board of Ophthalmology
Fellowship
- Oculoplastic Surgery, Massachusetts Eye and Ear Infirmary
Residency
- Ophthalmology, University of Southern California- Los Angeles
Internship
- Transitional, Memorial Sloan Kettering Cancer Center (GME)
Degree
- MD, University of California Davis School of Medicine
Academic title
- Clinical Professor
My expertise
Locations
My research
Publications
Showing 1-6 of 111 reviews
- August 27, 20265 out of 5 Stars
Dr. Lu is absolutely wonderful. He is very empathic. He treated my issues with my left eye very well.
- August 24, 20264.8 out of 5 Stars
I am very happy and pleased to have Dr. Lu as my opthomologist.
- August 7, 20265 out of 5 Stars
Excellent care and communication! Thank you Dr Lu and staff!!
- August 6, 20265 out of 5 Stars
Dr. Lu Is an exceptional Surgeon. He addressed All my medical issues and methodically explained to each and every one of them. He provided excellent post care And I'm very grateful to Have had my consultation with Dr. Lu
- August 3, 20265 out of 5 Stars
Because this is my third time having this surgery (different doctor) I am more nervous about it. Dr Lu was very kind and patient.
- July 16, 20265 out of 5 Stars
Excelllent
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.